Goodwin @ JPMorgan

Learn with Us: Goodwin + KPMG @ JPMorgan Symposium at the St. Regis Hotel

The St. Regis San Francisco
125 3rd Street
San Francisco, CA 94103

8:30 am – 8:45 am  Welcome Remarks

• Mitch Bloom, Chair, Life Sciences Practice, Goodwin
• Kristin Ciriello Pothier, Global Healthcare and Life Sciences Strategy Leader, KPMG (Moderator)

Burst 1: New Frontiers in Digital Diagnostics & Medtech

8:50 am – 9:05 am  Current State of the Healthcare Sector & Regulations

• Roger Cohen, Partner, Goodwin

9:10 am – 9:55 am  New Frontiers in MedTech Space on the Global Stage: What are the Challenges in IP, Regulatory and Commercial

• Kristin Ciriello Pothier, Global Healthcare and Life Sciences Strategy Leader, KPMG (Moderator)
• Nicholas Mitrokostas, Partner, Goodwin
• Stefan Scherer, Global Head of Experimental Medicine, GlaxoSmithKline (GSK)
• Joseph Zaccaria, Client Growth Director, TrialSpark
• Reena L. Pande, MD MSc, Chief Medical Officer, AbleTo

10:00 am – 10:45 am  Panel: Issues Facing Therapeutic Companies Using ML and AI in Drug Discovery Methods

• Danielle Lauzon, Partner, Goodwin (Moderator)
• David Berry, General Partner, Flagship; CEO, Integral
• Dan Housman, Co-founder, CTO Graticule, Co-founder Courage Therapeutics

Keynote Speech

10:55 am – 11:40 am  Keynote Speaker - Stéphane Bancel, CEO, Moderna

11:40 am – 12:10 pm  Lunch Break

Burst 2: Europe Unleashed

12:10 pm – 12:40 pm  The Evolving Landscape for Growth-Stage Venture Funding in Europe

• Sophie McGrath, Partner, Goodwin (Moderator)
• Francesco De Rubertis, Co-Founder and Partner, Medicxi
• Dirk Kersten, General Partner, Forbion

12:45 pm – 1:15 pm  Maximizing Returns through Structured M&As

• Graham Defries, Partner, Goodwin (Moderator)
• Erik van den Berg, CEO, AM-Pharma
• Geert-Jan Mulder, Co-Founder and Managing Partner, Forbion
• Maarten de Jong, Managing Director, Moelis & Company
• Andy Stephenson, Partner, Advisory, Financial Due Diligence, KPMG

Burst 3: Knowing the Best IPO Strategy

1:20 pm – 1:40 pm  2020 Vision for the IPO Market

• Amit Sinha, Managing Director, Investment Banking Division, Goldman Sachs

1:40 pm – 2:10 pm  Traditional US IPO Route: “The Two Minute Drill” to Complete a Successful IPO in the First Six Months of the Year

• Janet Lehman, National Leader, VC Life Sciences, KPMG (Moderator)
• Tom Koncsics, Partner, KPMG
• Michael Bison, Partner, Goodwin
• Jack Cassel, Vice President, Nasdaq
• Amit Sinha, Managing Director, Investment Banking Division, Goldman Sachs

2:15 pm – 2:45 pm  Hong Kong IPO: Seizing Opportunities in a New Emerging Market for Biotech IPOs

• Wendy Pan, Partner, Goodwin Hong Kong (Moderator)
• Irene Chu, Partner, Head of New Economy and Life Sciences, Hong Kong, KPMG China
• Michael Chan, Head of International Issuer Business, Hong Kong Exchanges and Clearing Limited (HKEX)
• Bin Li, Founder and Chief Investment Officer, Lake Bleu Capital 

2:50 pm – 3:20 pm  Alternatives to U.S. IPO: Reverse Mergers and Direct Listings

• Deepa Rich, Partner, Goodwin (Moderator)
• Gerry Schemidt, Partner, Audit, KPMG
• Mitchell H. Gold, Executive Chairman & CEO, Alpine Immune Sciences
• David Snyder, Chief Financial Officer, Exicure

3:20 pm – 3:30 pm  Coffee & Networking

Burst 4: Trends in Biopharma

3:30 pm – 4:10 pm  Evaluating and Partnering New Technologies and Emerging Business Models

• Kingsley Taft, Partner, Goodwin (Moderator)
• Jeffrey Stoll, Principal, National Life Sciences Strategy Leader, KPMG
• Nicholas Pullen, Ph.D., Executive Director of Inflammation & Immunology Integrative Sciences, Bristol-Myers Squibb

Burst 5: Mergers and Acquisitions

4:15 pm – 5:15 pm  The Brave New World of Antitrust in Life Sciences M&A

• Stuart Cable, Partner, Goodwin (Moderator)
• Lisa Haddad, Partner, Goodwin
• Andrea Murino, Partner, Goodwin

5:15 pm – 6:15 pm  Cocktails & Networking

Goodwin knows that succeeding in the life sciences industry is as much about strategy and execution as it is about research and development. In this highly competitive business, you need more than the best and brightest ideas - you need a legal and strategic partner that understands the challenges of securing funding, safeguarding intellectual property, establishing partnerships, bringing new products to market, opening up new revenue streams, and protecting existing products line.

Goodwin can help. We know the market, the players and the science. With a full service team of highly experienced lawyers resident in key life sciences hubs, Goodwin helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle.

Click here to learn more about Gooodwin's Life Sciences practice.